检索结果 - Julia Thornton Snider

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Effect of Hospital Use of Oral Nutritional Supplementation on Length of Stay, Hospital Cost, and 30-Day Readmissions Among Medicare Patients With COPD

    Effect of Hospital Use of Oral Nutritional Supplementation on Length of Stay, Hospital Cost, and 30-Day Readmissions Among Medicare Patients With COPD 由 Julia Thornton Snider, Anupam B. Jena, Mark T. Linthicum, Refaat Hegazi, Jamie Partridge, Chris LaVallee, Darius Lakdawalla, Paul E. Wischmeyer

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis

    Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis 由 Steve Kanters, Graeme Ball, Brad S. Kahl, Adriana Wiesinger, Eve H. Limbrick‐Oldfield, Akshay Sudhindra, Julia Thornton Snider, Anik R. Patel

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial

    The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial 由 Miguel‐Angel Perales, John Kuruvilla, Julia Thornton Snider, Sachin Vadgama, Rob Blissett, Fadoua El Moustaid, Nathaniel Smith, Anik R. Patel, Patrick B. Johnston

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients

    Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients 由 Yinong Young‐Xu, Robertus van Aalst, Salaheddin M. Mahmud, Kenneth J. Rothman, Julia Thornton Snider, Daniel Westreich, Vincent Mor, Stefan Gravenstein, Jason K. H. Lee, Edward W. Thommes, Michael D. Decker, Ayman Chit

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor

    Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated w... 由 Gilles Salles, Jenny M. H. Chen, Ina Zhang, Fábio R. Kerbauy, James J. Wu, Sally Wade, Ana Paiva Nunes, Chaoling Feng, Ioana Kloos, Weimin Peng, Julia Thornton Snider, Dylan Maciel, Keith Chan, Sam Keeping, Bijal Shah

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

    Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma 由 Paola Ghione, M. Lia Palomba, Anik R. Patel, Sabela Bobillo, Kevin Deighton, Caron A. Jacobson, Myrna Nahas, Anthony J. Hatswell, A. Scott Jung, Steve Kanters, Julia Thornton Snider, Sattva S. Neelapu, Teresa Ribeiro, M. Alan Brookhart, Hervé Ghesquières, John Radford, John G. Gribben

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study

    Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study 由 Paola Ghione, M. Lia Palomba, Hervé Ghesquières, Sabela Bobillo, Anik R. Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony J. Hatswell, Long Ma, Eve H. Limbrick‐Oldfield, Julia Thornton Snider, Sally Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John G. Gribben

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma 由 Jason R. Westin, Frederick L. Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B. Miklos, Matthew L. Ulrickson, Miguel‐Angel Perales, Umar Farooq, Luciano Wannesson, Lori A. Leslie, Marie José Kersten, Caron A. Jacobson, John M. Pagel, Gerald Wulf, Patrick B. Johnston, Aaron P. Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O. Oluwole, Anna Sureda

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma 由 Mahmoud Elsawy, Julio C. Chávez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob Rudzki, Saurabh Dahiya, Kathleen A. Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martı́n, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thiéblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei‐Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: